Your browser doesn't support javascript.
loading
The clinical impact of time to response in de novo accelerated-phase chronic myeloid leukemia.
Ohanian, Maro; Kantarjian, Hagop M; Shoukier, Mahran; Dellasala, Sara; Musaelyan, Arine; Nogueras Gonzalez, Graciela M; Jabbour, Elias; Abruzzo, Lynne; Verstovsek, Srdan; Borthakur, Gautam; Ravandi, Farhad; Garcia-Manero, Guillermo; Tamamyan, Gevorg; Champlin, Richard; Pierce, Sherry; Ferrajoli, Alessandra; Kadia, Tapan; Cortes, Jorge E.
Afiliação
  • Ohanian M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Shoukier M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Dellasala S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Musaelyan A; Department of Internal Medicine, RWJBH Healthcare System, Jersey City, New Jersey, USA.
  • Nogueras Gonzalez GM; Department of Biostatistics, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Abruzzo L; Department of Pathology, the Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Verstovsek S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Tamamyan G; Pediatric Cancer and Blood Disorders Center of Armenia, Yerevan State Medical University, Yerevan, Armenia.
  • Champlin R; Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ferrajoli A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Cortes JE; Georgia Cancer Center, Augusta, Georgia, USA.
Am J Hematol ; 95(10): 1127-1134, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32557828
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article